🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for IC-MPGN

Chinese Adults With Kidney Disease NCT07522099Phase 29 sites📍 Shenzhen📍 Guiyang📍 Zhengzhou ADARx Pharmaceuticals, Inc. · Tests: ADX-038, Telitacicept Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN NCT05755386Phase 3131 sites📍 Los Angeles📍 Orange📍 San Francisco Novartis Pharmaceuticals · Tests: Placebo, iptacopan Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN NCT03955445Phase 353 sites📍 Aurora📍 Lawrenceville📍 Iowa City Novartis Pharmaceuticals · Tests: LNP023 Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease NCT06989359Phase 238 sites📍 Doral📍 Miami📍 Pembroke Pines ADARx Pharmaceuticals, Inc. · Tests: ADX-038 Dose Level 2, ADX-038 Dose Level 1 Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study NCT07746895Phase 4101 sites📍 Kingswood📍 Woolloongabba📍 Graz Swedish Orphan Biovitrum · Tests: Pegcetacoplan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy